Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101501000B details a novel purification process for Montelukast using chiral amine salts, offering high optical purity and cost reduction in pharmaceutical intermediate manufacturing without chromatography.
Patent CN110668958A reveals a high-purity synthesis route for (R)-3-aminobutanol, a key Dolutegravir intermediate, offering significant cost and supply chain advantages.
Patent CN104263797A details a high-yield enzymatic resolution process for R-1-aminotetralin, offering significant supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103159633A reveals a scalable route for Tapentadol intermediates, eliminating chiral columns and harsh demethylation for cost-effective manufacturing.
Novel synthesis process for chiral N-BOC-pyrrolidine-2-boric acid offers improved yield and purity. Reliable supply chain solution for pharmaceutical intermediate manufacturing needs.
Patent CN1302116C reveals a novel enzymatic route for high-purity cyclopentene intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel catalytic route for posaconazole intermediate ensuring high purity and cost efficiency for pharmaceutical supply chains globally. This report analyzes patent CN115448911B for strategic sourcing.
Patent CN112500380A details a high-yield Ramelteon synthesis using NiCl2 reduction and S-Mandelic acid resolution, offering significant cost reduction and supply chain reliability.
Patent CN100558905C details a lipase-based resolution for high-purity chiral intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN102050800A details a cost-effective chiral resolution method for antidepressant intermediates, replacing complex asymmetric synthesis with scalable salt formation.
Patent CN104263798A details high-purity S-1-aminotetralin production via dynamic kinetic resolution offering significant supply chain and cost advantages.
Patent CN101045936B details a novel enzymatic resolution process using succinic anhydride, offering significant cost reduction and simplified purification for pharmaceutical intermediates.
Patent CN113087630A introduces a novel recycling method for (R)-(+)-alpha-phenylethylamine, ensuring high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN105061219A enables high-purity S-1-aminoindane via D-mandelic acid resolution. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel route from Itaconic Anhydride using chiral hydrogenation and lipase hydrolysis for high-purity Sacubitril intermediates. Cost-effective and scalable manufacturing solution.
Patent CN121318979A details a high-purity Poncirtinib Phosphate process. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel inclusion resolution method for high-purity Rabeprazole. Reduces costs and ensures supply chain stability for pharmaceutical intermediates.
Patent CN118852050B reveals a novel levamisole intermediate synthesis avoiding DMSO. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Patent CN105087744A details DKR method for high-purity S-5-methyl-1-amino indan. Offers cost reduction in pharma manufacturing and supply chain reliability.